The prescribed dosage for Sandostatin (octreotide acetate) may depend on a person’s individual treatment plan. Factors such as your medical history may affect your dosage of Sandostatin.

When Signifor LAR was approved in 2014, Novartis was suggesting it could become a replacement for its blockbuster Sandostatin LAR (octreotide acetate) depot product, which was making annual sales ...